• Phillygenin Targets Inflammation and Apoptosis in Diabetic N

  2026-05-24

  This study reveals that phillygenin, a natural compound from Forsythia suspensa, attenuates diabetic nephropathy by modulating TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling pathways. The findings offer mechanistic insight and highlight phillygenin as a promising candidate for anti-inflammatory and anti-apoptotic therapy in diabetic kidney disease.

• Shh, Fgf10, and Fgfr2 Govern Penile Urethral Development Div

  2026-05-23

  This study reveals how differential expression of Shh, Fgf10, and Fgfr2 orchestrates distinct mechanisms of prepuce and urethral groove formation in guinea pigs and mice. The findings provide mechanistic insights relevant for developmental biology and congenital malformation research.

• HyperScribe SP6 High Yield RNA Synthesis Kit: Advanced Workf

  2026-05-22

  Unlock high-yield, customizable RNA synthesis for translational research with the HyperScribe SP6 High Yield RNA Synthesis Kit. Explore practical workflows, troubleshooting advice, and actionable insights tailored for applications from RNAi to vaccine research.

• Netrin-1 Impairs Adipogenesis via PPARγ and Wnt/β-catenin Pa

  2026-05-22

  This study uncovers a previously unappreciated inhibitory role of adipose-derived Netrin-1 in high-fat-diet-induced adipogenesis. By delineating the molecular mechanisms involving PPARγ suppression and Wnt/β-catenin activation, the research clarifies how Netrin-1 modulates adipose remodeling and systemic metabolic health.

• ECL Chemiluminescent Substrate Detection Kit: Benchmarking L

  2026-05-21

  The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) delivers unrivaled sensitivity for immunoblotting, enabling confident detection of low picogram protein levels. Its extended signal duration and low background empower researchers to push the frontiers of low-abundance protein studies, as exemplified in translational periodontitis research.

• Pexidartinib (PLX3397): Modulating Microglia and Macrophages

  2026-05-21

  This thought-leadership article explores the mechanistic underpinnings and translational potential of Pexidartinib (PLX3397), a selective CSF1R inhibitor, in the context of tumor microenvironment modulation and neuroimmune research. Integrating recent literature, including pivotal findings on microglia-mediated neuronal dysregulation in alcohol-induced seizures, the article offers actionable strategic guidance for translational researchers, protocol parameters, and a forward-looking perspective on cross-domain opportunities.

• Applied Uses of (-)-Epigallocatechin Gallate (EGCG) in Biome

  2026-05-20

  (-)-Epigallocatechin gallate (EGCG) is a multifunctional green tea catechin with potent antioxidant, antiangiogenic, and antiviral activities. This article translates emerging reference data and validated workflows into actionable guidance for integrating EGCG into apoptosis, chemoprevention, and infection models—backed by troubleshooting tips and protocol enhancements.

• Cisplatin (CDDP): Optimizing Apoptosis and Tumor Inhibition

  2026-05-20

  Cisplatin (CDDP) is a gold-standard tool for dissecting DNA damage, apoptosis, and chemoresistance in cancer research. Explore advanced, data-driven workflows using APExBIO's high-purity Cisplatin to maximize assay reproducibility and interpretability.

• Apicidin Disrupts Oocyte Maturation via HDAC Inhibition Mech

  2026-05-19

  A recent study demonstrates that Apicidin, an emerging mycotoxin and histone deacetylase inhibitor, impairs oocyte quality by disrupting the meiotic apparatus and altering histone acetylation. These findings highlight the dual roles of Apicidin in both toxicology and epigenetic research, with significant implications for reproductive safety and laboratory applications.

• L-Alanyl-L-Glutamine in GI Barrier Research: Protocols & Pit

  2026-05-19

  L-Alanyl-L-Glutamine (L-Ala-L-Gln dipeptide) offers a stable, water-soluble alternative to free glutamine for advanced intestinal barrier and antioxidant system research. Explore practical workflow enhancements, troubleshooting, and the latest translational insights that set this dipeptide apart for gastrointestinal and inflammation models.

• Monoclonal Antibody Inhibits CD16a/b Shedding to Boost Tumor

  2026-05-18

  This study introduces F9H4, a monoclonal antibody that specifically inhibits the shedding of CD16a and CD16b on leukocytes, thereby enhancing antibody-dependent cellular cytotoxicity (ADCC) against tumors. By targeting substrate rather than protease, F9H4 provides a selective strategy to potentiate immune effector functions in cancer immunotherapy, with implications for improving the efficacy of Fc-enabled antibody therapies.

• Forskolin: Catalyzing Translational Breakthroughs in cAMP Bi

  2026-05-18

  This article explores the mechanistic, experimental, and strategic underpinnings of Forskolin as a direct adenylate cyclase activator, with a special focus on its role in stem cell biology, regeneration, and inflammation. Integrating evidence from a landmark mouse corneal epithelial cell paradigm, it provides actionable guidance for translational researchers and contextualizes Forskolin (APExBIO, B1421) within the evolving competitive and clinical landscape.

• T0070907: Precision PPARγ Antagonist for Signaling Pathway S

  2026-05-17

  T0070907 stands out as a potent PPARγ antagonist, enabling high-fidelity modulation of PPARγ signaling for research in adipogenesis, cancer biology, and cellular aging. This article details practical experimental workflows, troubleshooting strategies, and novel assay enhancements leveraging T0070907, translating emerging mechanistic insights into actionable protocols.

• Baicalein: Applied Protocols for Cancer and Inflammation Res

  2026-05-16

  Harness the power of Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) for precision inhibition of cancer cell proliferation and inflammation pathways. This article delivers step-by-step protocols, troubleshooting insights, and comparative analysis to maximize rigor and reproducibility in apoptosis and metabolic enzyme studies.

• HyperFusion High-Fidelity DNA Polymerase in Neurogenetic PCR

  2026-05-15

  HyperFusion™ high-fidelity DNA polymerase empowers researchers to overcome the toughest PCR challenges—especially in neurodegeneration and GC-rich template studies. Its unmatched fidelity, speed, and inhibitor tolerance set a new benchmark for accurate genotyping and complex amplicon sequencing.

414 records 8/28 page Previous Next First page 上5页 678910 下5页 Last page